Bocanegra Gondan AI, Ruiz-de-Angulo A, Zabaleta A, Gmez Blanco N, Cobaleda-Siles BM, Garca-Granda MJ, et al
You could also see a return of metabolic conditions, such as those associated with obesity (e.g
A: Most patients begin noticing improvements in sleep quality and recovery within 24 weeks
The trial in people with T2D included 281 participants (mean age 56 years, 56% women, mean BMI 35.0 kg/m 2 , mean HbA1c 8.3%) treated with lifestyle only and/or metformin, with similar intervention arms to the obesity trial, albeit retatrutide 0.5 mg rather than 1 mg, and dulaglutide 1.5 mg was an additional comparator [46]
The NHS recommends around 68 cups or glasses of fluid per day for most adults, with water, lower-fat milk, and sugar-free drinks all counting towards this total
A total of 8 different GLP-1 RAs were used (lixisenatide, liraglutide, exenatide, semaglutide, efpeglenatide, dulaglutide, albiglutide, and tirzepatide), each administered at therapeutic doses and compared vs placebo or controls